Selected transactions

Exclusive Financial Advisor to ERC for a share capital increase subscribed by UHNWI investors.

Exclusive Financial Advisor to NicOx SA on the acquisition of Laboratoires Doliage and concurrent entry into ancillary agreements with the Seller.

Exclusive Financial Advisor for the acquisition of a 80 % stake of the French premium dermo-cosmetics player Payot, alongside a renewal of Payot’s Management Team.

Exclusive Financial Advisor in the acquisition of Marinomed GmbH, a Biotechnology company developping anti-viral and immunological treatments, including Carragelose® anti-viral eye drop program.

Exclusive Financial Advisor to Alternext listed Novacyt SA on a merger with Lab21 Ltd.

Exclusive Financial Advisor to NicOx SA on the acquisition of Eupharmed S.r.l for an upfront consideration combined with a performance earn-out.

Exclusive Financial Advisor to Ekomir’s shareholders on the sale of the company to Valeant Pharmaceuticals.

Financial Advisor to Vemedia’s shareholders on the sale of a 78% stake to IK Investment Partners and a minority MBO to CEO.

Exclusive Financial Advisor to Italian healthcare company Scharper SpA on the sale of a majority stake to Italy-based group IdB Holding SpA.

Exclusive advisor to Biomérieux in the acquisition of AES Laboratoire, a leading French In-Vitro Diagnostics Group, specialized in industrial microbiological control.

Exclusive advisor, listing Sponsor and Sole Bookrunner for Novagali’s Initial Public Offering.

Exclusive Financial Advisor in the third-tranche of follow-on offerings corresponding to a capital increase with subscription rights for Transgene.